secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pyxis Oncology, Inc. (PYXS)
CIK:        0001782223
Form:       8-K
Filed at:   2024-10-23T23:59:59+00:00
Accession:  0000950170-24-116698
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pyxis Oncology shareholders approve 5.5M share increase in equity plan at special meeting
--------------------------------------------------------------------------------

- Shareholders voted 23,234,250 to 12,829,636 to approve amendment to 2021 Equity and Incentive Plan adding 5,500,000 shares.
- Proposal to adjourn if needed passed but was unnecessary; quorum of 36,189,305 shares present.
- 59,422,945 shares outstanding; special meeting held virtually on October 23, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782223/000095017024116698/0000950170-24-116698-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782223/000095017024116698/pyxs-20241023.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-116698

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer